AGRX
Price:
$1.51
Market Cap:
$10.43M
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend t...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-05-23
Stock Exchange
NASDAQ
Ticker
AGRX
According to Agile Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.89. This represents a change of 42.15% compared to the average of -0.62 of the last 4 quarters.
The mean historical PE Ratio of Agile Therapeutics, Inc. over the last ten years is -3.26. The current -0.89 PE Ratio has changed 2.62% with respect to the historical average. Over the past ten years (40 quarters), AGRX's PE Ratio was at its highest in in the March 2024 quarter at 0.24. The PE Ratio was at its lowest in in the December 2017 quarter at -7377.92.
Average
-3.26
Median
-3.65
Minimum
-7.08
Maximum
-0.02
Discovering the peaks and valleys of Agile Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.15%
Maximum Annual PE Ratio = -0.02
Minimum Annual Increase = -99.65%
Minimum Annual PE Ratio = -7.08
Year | PE Ratio | Change |
---|---|---|
2023 | -0.29 | 50.61% |
2022 | -0.19 | 1.15% |
2021 | -0.02 | -99.65% |
2020 | -4.44 | -33.67% |
2019 | -6.70 | 570.54% |
2018 | -1.00 | -66.02% |
2017 | -2.94 | -47.56% |
2016 | -5.61 | -20.84% |
2015 | -7.08 | 62.78% |
2014 | -4.35 | 24.59% |
The current PE Ratio of Agile Therapeutics, Inc. (AGRX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.17
5-year avg
-2.33
10-year avg
-3.26
Agile Therapeutics, Inc.’s PE Ratio is greater than Assertio Holdings, Inc. (-1.22), greater than Amneal Pharmaceuticals, Inc. (-13.18), greater than AcelRx Pharmaceuticals, Inc. (-1.04), less than Lifecore Biomedical, Inc. (35.87), less than Guardion Health Sciences, Inc. (0.65), greater than Alpha Teknova, Inc. (-12.08), less than Cyclo Therapeutics, Inc. (-0.69), less than Petros Pharmaceuticals, Inc. (-0.27), less than Shuttle Pharmaceuticals Holdings, Inc. (-0.22), less than Mallinckrodt plc (-0.04), less than Athenex, Inc. (-0.01), greater than Evoke Pharma, Inc. (-1.12), greater than Cumberland Pharmaceuticals Inc. (-3.25), less than PainReform Ltd. (-0.87), greater than Aquestive Therapeutics, Inc. (-9.11),
Company | PE Ratio | Market cap |
---|---|---|
-1.22 | $83.65M | |
-13.18 | $3.63B | |
-1.04 | $14.58M | |
35.87 | $279.89M | |
0.65 | $4.35M | |
-12.08 | $458.45M | |
-0.69 | $17.12M | |
-0.27 | $2.89M | |
-0.22 | $3.04M | |
-0.04 | $4.52M | |
-0.01 | $2.33M | |
-1.12 | $7.28M | |
-3.25 | $35.25M | |
-0.87 | $2.62M | |
-9.11 | $320.95M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Agile Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Agile Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Agile Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Agile Therapeutics, Inc. (AGRX)?
What is the highest PE Ratio for Agile Therapeutics, Inc. (AGRX)?
What is the 3-year average PE Ratio for Agile Therapeutics, Inc. (AGRX)?
What is the 5-year average PE Ratio for Agile Therapeutics, Inc. (AGRX)?
How does the current PE Ratio for Agile Therapeutics, Inc. (AGRX) compare to its historical average?